EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

The AAHKS Clinical Research Award: Extended Postoperative Oral Tranexamic Acid in Total Knee Arthroplasty: A Randomized Controlled Pilot Study

Mateo J Kirwan, Zachary R Diltz, Derek T Dixon, Carlos A Rivera-Peraza, Christal J Gammage, Willliam M Mihalko, James W Harkess, James L Guyton, John R Crockarell, Marcus C Ford

The Journal of Arthroplasty · 2024-09 · 39 (9) · S13-S17

DOI: 10.1016/j.arth.2024.02.073 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Arthroplasty, 2024-09. Verfasst von Mateo J Kirwan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery and Biomedical Engineering, Health Science Center-Campbell Clinic, University of Tennessee, Memphis, Tennessee. Hauptthemen laut MEDLINE: Tranexamic Acid, Arthroplasty, Replacement, Knee, Antifibrinolytic Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Perioperative tranexamic acid (TXA) use with total knee arthroplasty (TKA) is widely accepted today. Recently, a few international groups have published on the safety and outcomes of extending TXA use in the postoperative period. Through a double-blinded, randomized control trial (RCT), we aimed to investigate the safety and clinical efficacy of extended postoperative oral TXA use in TKA performed in an American, free-standing ambulatory surgery center (ASC). METHODS: Based on a power analysis, 40 patients undergoing primary TKA were randomized into 2 groups: extended oral TXA versus placebo. Both groups received a standard 1g intravenous TXA dose prior to incision and at the time of closure. The extended TXA group received an additional 1.95 g oral TXA dose following ambulation the day of surgery, plus on postoperative days 1,2, and 3. Patients who had a history of venous thromboembolism (VTE) or cancer were excluded. All patients received 81 mg of aspirin twice daily for VTE prophylaxis. Patients were followed on postoperative day 3 and weeks 2 and 6. Paired t-tests determined statistical significance. RESULTS: Extended TXA patients showed significantly increased knee flexion at 6 weeks (116.05 versus 106.5, P = .0308), improved VAS at 2 (2.5 versus 3.85, P = .039) and 6 weeks (1.35 versus 2.8, P = .011), and superior KOOS JR at 2 (66.87 versus 60.63, P = .03) and 6 weeks (73.33 versus 62.47, P = .0019) compared to placebo patients. No significant differences were found for changes in hemoglobin levels at any time points. No significant differences were found at 12 weeks for any clinical endpoints. No adverse events were noted in either cohort. CONCLUSIONS: When compared to placebo, the extended use of oral TXA in the postoperative period may safely result in improved motion, pain, and functional scores. Further investigation into 1-to-2-year outcomes, as well as the duration and dose of postoperative TXA use is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidArthroplasty, Replacement, KneeAntifibrinolytic AgentsHumansPilot ProjectsMaleFemaleDouble-Blind MethodAgedMiddle AgedAdministration, OralAwards and PrizesTreatment OutcomeVenous Thromboembolism

Stichwörter der Autor:innen

ambulatory surgery centerarthroplastyextended tranexamic acidtotal knee arthroplastytranexamic acid

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery and Biomedical Engineering, Health Science Center-Campbell Clinic, University of Tennessee, Memphis, Tennessee.
  • The Campbell Clinic Foundation, Memphis, Tennessee.

Zitieren

APA

Kirwan, M. J., Diltz, Z. R., Dixon, D. T., Rivera-Peraza, C. A., Gammage, C. J., Mihalko, W. M., Harkess, J. W., Guyton, J. L., Crockarell, J. R., & Ford, M. C. (2024). The AAHKS Clinical Research Award: Extended Postoperative Oral Tranexamic Acid in Total Knee Arthroplasty: A Randomized Controlled Pilot Study. The Journal of Arthroplasty, 39(9), S13-S17. https://doi.org/10.1016/j.arth.2024.02.073

Vancouver

Kirwan MJ, Diltz ZR, Dixon DT, Rivera-Peraza CA, Gammage CJ, Mihalko WM, et al. The AAHKS Clinical Research Award: Extended Postoperative Oral Tranexamic Acid in Total Knee Arthroplasty: A Randomized Controlled Pilot Study. The Journal of Arthroplasty. 2024;39(9):S13-S17. doi:10.1016/j.arth.2024.02.073

BibTeX
@article{Kirwan2024,
  author = {Kirwan, Mateo J and Diltz, Zachary R and Dixon, Derek T and Rivera-Peraza, Carlos A and Gammage, Christal J and Mihalko, Willliam M and Harkess, James W and Guyton, James L and Crockarell, John R and Ford, Marcus C},
  title = {The AAHKS Clinical Research Award: Extended Postoperative Oral Tranexamic Acid in Total Knee Arthroplasty: A Randomized Controlled Pilot Study},
  journal = {The Journal of Arthroplasty},
  year = {2024},
  volume = {39},
  number = {9},
  pages = {S13--S17},
  doi = {10.1016/j.arth.2024.02.073}
}
Kostenlos starten →